Vertebral Technologies (VTI) received notice of allowance for its patent, “Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices.” This follows a 1Q17 patent grant for modular, in vivo assembly technology and the motion preservation InterCushion® pipeline product.
VTI has 28 patents and patent pending assets in its global intellectual property portfolio. The company’s InterFuse® intra-operative assembly technology allows surgeons to implant a large footprint device through a minimally invasive approach.
Vertebral Technologies (VTI) received notice of allowance for its patent, "Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices." This follows a 1Q17 patent grant for modular, in vivo assembly technology and the motion preservation InterCushion® pipeline product.
VTI has 28 patents and patent pending assets in its...
Vertebral Technologies (VTI) received notice of allowance for its patent, “Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices.” This follows a 1Q17 patent grant for modular, in vivo assembly technology and the motion preservation InterCushion® pipeline product.
VTI has 28 patents and patent pending assets in its global intellectual property portfolio. The company’s InterFuse® intra-operative assembly technology allows surgeons to implant a large footprint device through a minimally invasive approach.
Copy to clipboard 
